British Columbia Investment Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.47M Sell
27,310
-7,742
-22% -$710K 0.01% 546
2025
Q4
$3.15M Buy
35,052
+6,619
+23% +$628K 0.02% 534
2025
Q3
$2.8M Sell
28,433
-2,704
-9% -$268K 0.02% 505
2025
Q2
$2.84M Sell
31,137
-6,942
-18% -$671K 0.02% 505
2025
Q1
$4.31M Sell
38,079
-920
-2% -$98.4K 0.03% 434
2024
Q4
$4.12M Buy
38,999
+4,672
+14% +$501K 0.02% 459
2024
Q3
$3.71M Sell
34,327
-4,955
-13% -$541K 0.02% 442
2024
Q2
$4.26M Buy
39,282
+14,332
+57% +$1.69M 0.03% 419
2024
Q1
$3.29M Buy
24,950
+888
+4% +$111K 0.02% 424
2023
Q4
$2.93M Buy
24,062
+5,149
+27% +$575K 0.02% 422
2023
Q3
$2.12M Hold
18,913
0.02% 429
2023
Q2
$2.75M Buy
18,913
+188
+1% +$25.5K 0.03% 397
2023
Q1
$2.42M Buy
18,725
+139
+0.7% +$17.5K 0.03% 414
2022
Q4
$2.37M Sell
18,586
-2,150
-10% -$250K 0.03% 410
2022
Q3
$2.17M Sell
20,736
-3,419
-14% -$375K 0.02% 432
2022
Q2
$2.54M Sell
24,155
-8,097
-25% -$961K 0.02% 450
2022
Q1
$4.13M Sell
32,252
-5,518
-15% -$665K 0.03% 436
2021
Q4
$4.66M Sell
37,770
-1,869
-5% -$245K 0.03% 459
2021
Q3
$5.63M Buy
39,639
+21
+0.1% +$3.09K 0.03% 406
2021
Q2
$6.19M Buy
39,618
+4,634
+13% +$751K 0.04% 385
2021
Q1
$5.44M Sell
34,984
-1,079
-3% -$167K 0.04% 368
2020
Q4
$5.39M Sell
36,063
-880
-2% -$124K 0.04% 359
2020
Q3
$4.88M Buy
36,943
+2,876
+8% +$376K 0.04% 340
2020
Q2
$3.95M Buy
34,067
+10,893
+47% +$1.26M 0.04% 361
2020
Q1
$2.27M Sell
23,174
-26,704
-54% -$3.5M 0.04% 338
2019
Q4
$7.25M Buy
49,878
+19,465
+64% +$2.69M 0.05% 273
2019
Q3
$4.05M Sell
30,413
-13,592
-31% -$1.76M 0.04% 411
2019
Q2
$5.03M Buy
44,005
+4,445
+11% +$521K 0.04% 436
2019
Q1
$4.91M Sell
39,560
-39,230
-50% -$4.46M 0.04% 430
2018
Q4
$7.93M Buy
78,790
+35,014
+80% +$3.94M 0.07% 284
2018
Q3
$5.59M Sell
43,776
-19,135
-30% -$2.28M 0.06% 374
2018
Q2
$6.81M Sell
62,911
-15,546
-20% -$1.69M 0.06% 377
2018
Q1
$8.31M Sell
78,457
-4,973
-6% -$578K 0.06% 361
2017
Q4
$9.77M Buy
83,430
+319
+0.4% +$36.1K 0.07% 327
2017
Q3
$9.45M Sell
83,111
-1,374
-2% -$159K 0.07% 313
2017
Q2
$10.5M Buy
84,485
+5,150
+6% +$611K 0.08% 295
2017
Q1
$9.4M Buy
79,335
+5,931
+8% +$672K 0.07% 349
2016
Q4
$7.36M Buy
73,404
+13,111
+22% +$1.41M 0.06% 355
2016
Q3
$7.61M Sell
60,293
-51,422
-46% -$6.35M 0.08% 312
2016
Q2
$13.1M Buy
111,715
+44,509
+66% +$5.04M 0.11% 207
2016
Q1
$6.96M Buy
67,206
+6,966
+12% +$674K 0.07% 345
2015
Q4
$6M Buy
60,240
+20,100
+50% +$1.97M 0.06% 378
2015
Q3
$3.66M Sell
40,140
-8,800
-18% -$882K 0.04% 435
2015
Q2
$5.19M Sell
48,940
-57,055
-54% -$6.31M 0.05% 402
2015
Q1
$12.1M Sell
105,995
-29,418
-22% -$3.36M 0.11% 245
2014
Q4
$14.9M Buy
135,413
+22,580
+20% +$2.38M 0.12% 211
2014
Q3
$11M Buy
112,833
+39,024
+53% +$3.84M 0.09% 264
2014
Q2
$7.44M Sell
73,809
-1,876
-2% -$183K 0.06% 350
2014
Q1
$6.95M Sell
75,685
-11,357
-13% -$1.05M 0.06% 358
2013
Q4
$7.88M Sell
87,042
-23,845
-22% -$2.06M 0.06% 339
2013
Q3
$8.84M Sell
110,887
-26,664
-19% -$2.1M 0.07% 310
2013
Q2
$10M Buy
+137,551
New +$10.3M 0.08% 289

Other funds holding ZBH

British Columbia Investment Management's ZBH Position: Q1 2026 in Review

British Columbia Investment Management reduced its Zimmer Biomet (ZBH) stake by 22% in Q1 2026, selling an estimated $710K and leaving 27,310 shares worth $2.47M. The position accounts for 0.01% of the portfolio, ranked #546.

British Columbia Investment Management first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $14.9M in Q4 2014. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • British Columbia Investment Management held 27,310 shares of Zimmer Biomet worth $2.47M as of Q1 2026.
  • British Columbia Investment Management sold 7,742 Zimmer Biomet shares in Q1 2026, an estimated $710K.
  • Zimmer Biomet made up 0.01% of British Columbia Investment Management's portfolio in Q1 2026, its #546 holding.
  • British Columbia Investment Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • British Columbia Investment Management's Zimmer Biomet position peaked at $14.9M in Q4 2014.
  • 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on British Columbia Investment Management's 13F filing for Q1 2026, filed 14 May 2026.